Literature DB >> 3449121

Grading of dyspnoea and walking speed in cardiac disease and in chronic airflow obstruction.

A R Warley1, O C Finnegan, E M Nicholson, G Laszlo.   

Abstract

A five-point dyspnoea scale (modified MRC questionnaire) and 12-minute walking test were used to compare the relationship between subjective assessment of dyspnoea and objective measurement of disability in patients with chronic airflow limitation, cardiac disease, and normal subjects. There was no overall difference in exercise performance between the cardiac and respiratory groups. There was a significant correlation between vital capacity and exercise performance, and the slope of the regression line was similar in the two groups. There was no correlation between vital capacity and exercise performance in the group of normal subjects. The five-point dyspnoea scale predicts similar levels of performance in the 12-minute walking test whether the dyspnoea is a result of cardiac or respiratory disease.

Entities:  

Mesh:

Year:  1987        PMID: 3449121     DOI: 10.1016/0007-0971(87)90183-5

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  2 in total

1.  Development and initial validation of a self-assessed lupus organ damage instrument.

Authors:  Karen H Costenbader; Munther Khamashta; Silvia Ruiz-Garcia; Maria Teresa Perez-Rodriguez; Michelle Petri; Jennifer Elliott; Susan Manzi; Elizabeth W Karlson; Tabitha Turner-Stokes; Bonnie Bermas; Jonathan Coblyn; Elena Massarotti; Peter Schur; Patricia Fraser; Iris Navarro; John G Hanly; Timothy S Shaver; Robert S Katz; Eliza Chakravarty; Paul R Fortin; Martha L Sanchez; Jigna Liu; Kaleb Michaud; Graciela S Alarcón; Frederick Wolfe
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

2.  Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes.

Authors:  John R Hurst; Sarita Workman; Davinder S Garcha; Suranjith L Seneviratne; Jamanda A Haddock; Bodo Grimbacher
Journal:  J Clin Immunol       Date:  2013-10-18       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.